Feasibility of salvage resection following locoregional failure after chemoradiotherapy and consolidation durvalumab for unresectable stage III non-small cell lung cancer-Reference-Cited by-同舟云学术

Feasibility of salvage resection following locoregional failure after chemoradiotherapy and consolidation durvalumab for unresectable stage III non-small cell lung cancer

Published:2023-08 Issue: Volume:182 Page:107294
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Dickhoff C.^ORCID,Unal S.,Heineman D.J.,Winkelman J.A.,Braun J.,Bahce I.,van Dorp M.,Senan S.,Dahele M.

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference17 articles.

1. Five-year survival outcomes from the PACIFIC trial: durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer;Spigel;J. Clin. Oncol.,2022

2. Locoregional control, failure patterns and clinical outcomes in patients with stage III non-small cell lung cancers treated with chemoradiation and durvalumab;Offin;J. Clin. Oncol.,2020

3. Salvage surgery for locoregional recurrence or persistent tumor after high dose chemoradiotherapy for locally advanced non-small cell lung cancer;Dickhoff;Lung Cancer,2016

4. Dickhoff C, Otten RHJ, Heymans MW, et al. Salvage surgery for recurrent or persistent tumour after radical (chemo)radiotherapy for locally advanced non-small cell lung cancer: a systematic review. Ther. Adv. Med. Oncol. 2018;10:1-12.

5. Neoadjuvant PD-1 blockade in resectable lung cancer;Forde;N. Engl. J. Med.,2018

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathological complete response after primary tumor surgery following chemoimmunotherapy and stereotactic radiosurgery of initially metastatic non-small-cell lung cancer;Srpski arhiv za celokupno lekarstvo;2024